Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis
Mutations in Connexin26 (Cx26) give rise to a spectrum of dominantly inherited hyperproliferating skin disorders, the severest being keratitis–ichthyosis–deafness (KID) syndrome, an inflammatory skin disorder, with patients prone to opportunistic infections. We compared the effects of peptidoglycan...
Gespeichert in:
Veröffentlicht in: | Experimental dermatology 2012-08, Vol.21 (8), p.592-598 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 598 |
---|---|
container_issue | 8 |
container_start_page | 592 |
container_title | Experimental dermatology |
container_volume | 21 |
creator | Donnelly, Steven English, Grant de Zwart-Storm, Eugene A. Lang, Sue van Steensel, Maurice A. M. Martin, Patricia E. |
description | Mutations in Connexin26 (Cx26) give rise to a spectrum of dominantly inherited hyperproliferating skin disorders, the severest being keratitis–ichthyosis–deafness (KID) syndrome, an inflammatory skin disorder, with patients prone to opportunistic infections. We compared the effects of peptidoglycan (PGN) extracted from the skin commensal Staphylococcus epidermidis and the opportunistic pathogen Staphylococcus aureus on interleukin‐6 and connexin expression in HaCaT cells (a keratinocyte cell line) and connexin channel activity in HaCaT and HeLa (connexin deficient) cells transfected to express KID and non‐KID Cx26 mutations. In both cell types, PGN from S. aureus induced hemichannel activity in cells expressing KID mutants as monitored by ATP release assays following 15‐min challenge, while that from S. epidermidis evoked a response in HeLa cells. In KID mutant expressing cells, ATP release was significantly higher than in cells transfected with wild‐type Cx26. No ATP release was observed in non‐KID mutant transfected cells or in the presence of carbenoxolone, a connexin channel blocker. PGN isolated from S. aureus but not S. epidermidis induced interleukin‐6 and Cx26 expression in HaCaT cells following 6‐h challenge. Challenge by PGN from S. aureus evoked a greater interleukin‐6 response in cells expressing KID mutants than in cells expressing wtCx26 or non‐KID mutants. This response returned to basal levels if acute KID hemichannel signalling was blocked prior to PGN challenge. Thus, KID mutants form channels that can be triggered by the pro‐inflammatory mediator PGN from opportunistic pathogens but not skin commensals, providing further insight into the genotype–phenotype relationship of Cx26 disorders. |
doi_str_mv | 10.1111/j.1600-0625.2012.01521.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1038601362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1038601362</sourcerecordid><originalsourceid>FETCH-LOGICAL-i3661-fac827d31747fd4ff1678fa910e9626b500834abd0012a1ea1781a7b9bb7b2bc3</originalsourceid><addsrcrecordid>eNqNks-O0zAQxi0EYkvhFZAvSFwSPHZitwcOqLvsrnaBA6BysyaJzbrkH7HDNg_Ee-LQUiRO-DKW5vd9I818hFBgKcT3apeCZCxhkucpZ8BTBjmHdP-ALE6Nh2TB1kwmUrH8jDzxfscYKKHyx-SMc5kJ4PmC_Dx31prBtMFhTf3oS9MHV7jahYl2lm72XNJmDBhc13qK3nelw2Aqeu_CHTW9q8zQRGk1-b5G79DT0NF-dqm6r_VUYksj4n5EiR26hn4M2N9NdVd2ZTlGx3Ewc2mrfztHb1c5_5Q8slh78-xYl-Tz24tPm6vk9sPl9ebNbeKElJBYLFdcVQJUpmyVWQtSrSyugZm15LLIGVuJDIsqboIjGAS1AlTFuihUwYtSLMnLg28_dN9H44NuXNxIXWNrutFrYGIlGQjJ_wPlWaaUEjKiz4_oWDSm0v3gGhwm_ecKEXhxBNCXWNsB29L5v5yEXEGcvSSvD9y9q8106gPTcyr0Ts_H1_Px9ZwK_TsVeq8vvpzPv6hPDnrng9mf9Dh803JOht6-v9Qyfwc3fLvVN-IXObi9cQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1024477736</pqid></control><display><type>article</type><title>Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Donnelly, Steven ; English, Grant ; de Zwart-Storm, Eugene A. ; Lang, Sue ; van Steensel, Maurice A. M. ; Martin, Patricia E.</creator><creatorcontrib>Donnelly, Steven ; English, Grant ; de Zwart-Storm, Eugene A. ; Lang, Sue ; van Steensel, Maurice A. M. ; Martin, Patricia E.</creatorcontrib><description>Mutations in Connexin26 (Cx26) give rise to a spectrum of dominantly inherited hyperproliferating skin disorders, the severest being keratitis–ichthyosis–deafness (KID) syndrome, an inflammatory skin disorder, with patients prone to opportunistic infections. We compared the effects of peptidoglycan (PGN) extracted from the skin commensal Staphylococcus epidermidis and the opportunistic pathogen Staphylococcus aureus on interleukin‐6 and connexin expression in HaCaT cells (a keratinocyte cell line) and connexin channel activity in HaCaT and HeLa (connexin deficient) cells transfected to express KID and non‐KID Cx26 mutations. In both cell types, PGN from S. aureus induced hemichannel activity in cells expressing KID mutants as monitored by ATP release assays following 15‐min challenge, while that from S. epidermidis evoked a response in HeLa cells. In KID mutant expressing cells, ATP release was significantly higher than in cells transfected with wild‐type Cx26. No ATP release was observed in non‐KID mutant transfected cells or in the presence of carbenoxolone, a connexin channel blocker. PGN isolated from S. aureus but not S. epidermidis induced interleukin‐6 and Cx26 expression in HaCaT cells following 6‐h challenge. Challenge by PGN from S. aureus evoked a greater interleukin‐6 response in cells expressing KID mutants than in cells expressing wtCx26 or non‐KID mutants. This response returned to basal levels if acute KID hemichannel signalling was blocked prior to PGN challenge. Thus, KID mutants form channels that can be triggered by the pro‐inflammatory mediator PGN from opportunistic pathogens but not skin commensals, providing further insight into the genotype–phenotype relationship of Cx26 disorders.</description><identifier>ISSN: 0906-6705</identifier><identifier>EISSN: 1600-0625</identifier><identifier>DOI: 10.1111/j.1600-0625.2012.01521.x</identifier><identifier>PMID: 22643125</identifier><language>eng</language><publisher>Oxford: Blackwell Publishing Ltd</publisher><subject>Adenosine Triphosphate - metabolism ; ATP ; Bacterial diseases ; Biological and medical sciences ; Carbenoxolone - pharmacology ; Cell Line ; Channel gating ; Commensals ; Complex syndromes ; Connexin 26 ; connexin26 ; Connexins ; Connexins - genetics ; Connexins - metabolism ; Deafness - genetics ; Dermatology ; disorder ; Dyskeratosis ; Dysplasia ; Epidermis - abnormalities ; Genotype ; HeLa Cells ; hemichannel activity ; Human bacterial diseases ; Humans ; Ichthyosis - genetics ; Infectious diseases ; Inflammation ; Inflammatory diseases ; innate immunity ; Interleukin 6 ; Interleukin-6 - metabolism ; Keratinocytes ; Keratinocytes - drug effects ; Keratinocytes - metabolism ; Keratinocytes - pathology ; Keratitis - genetics ; KID syndrome ; Medical genetics ; Medical sciences ; Mutation ; Mutation - genetics ; Opportunist infection ; Pathogens ; Peptidoglycan - metabolism ; Peptidoglycan - pharmacology ; peptidoglycans ; Phenotype ; Skin ; Skin Diseases, Genetic - genetics ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Staphylococcus aureus ; Staphylococcus aureus - metabolism ; Staphylococcus epidermidis ; Staphylococcus epidermidis - metabolism ; Transfection</subject><ispartof>Experimental dermatology, 2012-08, Vol.21 (8), p.592-598</ispartof><rights>2012 John Wiley & Sons A/S</rights><rights>2015 INIST-CNRS</rights><rights>2012 John Wiley & Sons A/S.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-0625.2012.01521.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-0625.2012.01521.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26157110$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22643125$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Donnelly, Steven</creatorcontrib><creatorcontrib>English, Grant</creatorcontrib><creatorcontrib>de Zwart-Storm, Eugene A.</creatorcontrib><creatorcontrib>Lang, Sue</creatorcontrib><creatorcontrib>van Steensel, Maurice A. M.</creatorcontrib><creatorcontrib>Martin, Patricia E.</creatorcontrib><title>Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis</title><title>Experimental dermatology</title><addtitle>Exp Dermatol</addtitle><description>Mutations in Connexin26 (Cx26) give rise to a spectrum of dominantly inherited hyperproliferating skin disorders, the severest being keratitis–ichthyosis–deafness (KID) syndrome, an inflammatory skin disorder, with patients prone to opportunistic infections. We compared the effects of peptidoglycan (PGN) extracted from the skin commensal Staphylococcus epidermidis and the opportunistic pathogen Staphylococcus aureus on interleukin‐6 and connexin expression in HaCaT cells (a keratinocyte cell line) and connexin channel activity in HaCaT and HeLa (connexin deficient) cells transfected to express KID and non‐KID Cx26 mutations. In both cell types, PGN from S. aureus induced hemichannel activity in cells expressing KID mutants as monitored by ATP release assays following 15‐min challenge, while that from S. epidermidis evoked a response in HeLa cells. In KID mutant expressing cells, ATP release was significantly higher than in cells transfected with wild‐type Cx26. No ATP release was observed in non‐KID mutant transfected cells or in the presence of carbenoxolone, a connexin channel blocker. PGN isolated from S. aureus but not S. epidermidis induced interleukin‐6 and Cx26 expression in HaCaT cells following 6‐h challenge. Challenge by PGN from S. aureus evoked a greater interleukin‐6 response in cells expressing KID mutants than in cells expressing wtCx26 or non‐KID mutants. This response returned to basal levels if acute KID hemichannel signalling was blocked prior to PGN challenge. Thus, KID mutants form channels that can be triggered by the pro‐inflammatory mediator PGN from opportunistic pathogens but not skin commensals, providing further insight into the genotype–phenotype relationship of Cx26 disorders.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>ATP</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Carbenoxolone - pharmacology</subject><subject>Cell Line</subject><subject>Channel gating</subject><subject>Commensals</subject><subject>Complex syndromes</subject><subject>Connexin 26</subject><subject>connexin26</subject><subject>Connexins</subject><subject>Connexins - genetics</subject><subject>Connexins - metabolism</subject><subject>Deafness - genetics</subject><subject>Dermatology</subject><subject>disorder</subject><subject>Dyskeratosis</subject><subject>Dysplasia</subject><subject>Epidermis - abnormalities</subject><subject>Genotype</subject><subject>HeLa Cells</subject><subject>hemichannel activity</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Ichthyosis - genetics</subject><subject>Infectious diseases</subject><subject>Inflammation</subject><subject>Inflammatory diseases</subject><subject>innate immunity</subject><subject>Interleukin 6</subject><subject>Interleukin-6 - metabolism</subject><subject>Keratinocytes</subject><subject>Keratinocytes - drug effects</subject><subject>Keratinocytes - metabolism</subject><subject>Keratinocytes - pathology</subject><subject>Keratitis - genetics</subject><subject>KID syndrome</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Mutation</subject><subject>Mutation - genetics</subject><subject>Opportunist infection</subject><subject>Pathogens</subject><subject>Peptidoglycan - metabolism</subject><subject>Peptidoglycan - pharmacology</subject><subject>peptidoglycans</subject><subject>Phenotype</subject><subject>Skin</subject><subject>Skin Diseases, Genetic - genetics</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - metabolism</subject><subject>Staphylococcus epidermidis</subject><subject>Staphylococcus epidermidis - metabolism</subject><subject>Transfection</subject><issn>0906-6705</issn><issn>1600-0625</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks-O0zAQxi0EYkvhFZAvSFwSPHZitwcOqLvsrnaBA6BysyaJzbrkH7HDNg_Ee-LQUiRO-DKW5vd9I818hFBgKcT3apeCZCxhkucpZ8BTBjmHdP-ALE6Nh2TB1kwmUrH8jDzxfscYKKHyx-SMc5kJ4PmC_Dx31prBtMFhTf3oS9MHV7jahYl2lm72XNJmDBhc13qK3nelw2Aqeu_CHTW9q8zQRGk1-b5G79DT0NF-dqm6r_VUYksj4n5EiR26hn4M2N9NdVd2ZTlGx3Ewc2mrfztHb1c5_5Q8slh78-xYl-Tz24tPm6vk9sPl9ebNbeKElJBYLFdcVQJUpmyVWQtSrSyugZm15LLIGVuJDIsqboIjGAS1AlTFuihUwYtSLMnLg28_dN9H44NuXNxIXWNrutFrYGIlGQjJ_wPlWaaUEjKiz4_oWDSm0v3gGhwm_ecKEXhxBNCXWNsB29L5v5yEXEGcvSSvD9y9q8106gPTcyr0Ts_H1_Px9ZwK_TsVeq8vvpzPv6hPDnrng9mf9Dh803JOht6-v9Qyfwc3fLvVN-IXObi9cQ</recordid><startdate>201208</startdate><enddate>201208</enddate><creator>Donnelly, Steven</creator><creator>English, Grant</creator><creator>de Zwart-Storm, Eugene A.</creator><creator>Lang, Sue</creator><creator>van Steensel, Maurice A. M.</creator><creator>Martin, Patricia E.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>201208</creationdate><title>Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis</title><author>Donnelly, Steven ; English, Grant ; de Zwart-Storm, Eugene A. ; Lang, Sue ; van Steensel, Maurice A. M. ; Martin, Patricia E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i3661-fac827d31747fd4ff1678fa910e9626b500834abd0012a1ea1781a7b9bb7b2bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>ATP</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Carbenoxolone - pharmacology</topic><topic>Cell Line</topic><topic>Channel gating</topic><topic>Commensals</topic><topic>Complex syndromes</topic><topic>Connexin 26</topic><topic>connexin26</topic><topic>Connexins</topic><topic>Connexins - genetics</topic><topic>Connexins - metabolism</topic><topic>Deafness - genetics</topic><topic>Dermatology</topic><topic>disorder</topic><topic>Dyskeratosis</topic><topic>Dysplasia</topic><topic>Epidermis - abnormalities</topic><topic>Genotype</topic><topic>HeLa Cells</topic><topic>hemichannel activity</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Ichthyosis - genetics</topic><topic>Infectious diseases</topic><topic>Inflammation</topic><topic>Inflammatory diseases</topic><topic>innate immunity</topic><topic>Interleukin 6</topic><topic>Interleukin-6 - metabolism</topic><topic>Keratinocytes</topic><topic>Keratinocytes - drug effects</topic><topic>Keratinocytes - metabolism</topic><topic>Keratinocytes - pathology</topic><topic>Keratitis - genetics</topic><topic>KID syndrome</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Mutation</topic><topic>Mutation - genetics</topic><topic>Opportunist infection</topic><topic>Pathogens</topic><topic>Peptidoglycan - metabolism</topic><topic>Peptidoglycan - pharmacology</topic><topic>peptidoglycans</topic><topic>Phenotype</topic><topic>Skin</topic><topic>Skin Diseases, Genetic - genetics</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - metabolism</topic><topic>Staphylococcus epidermidis</topic><topic>Staphylococcus epidermidis - metabolism</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Donnelly, Steven</creatorcontrib><creatorcontrib>English, Grant</creatorcontrib><creatorcontrib>de Zwart-Storm, Eugene A.</creatorcontrib><creatorcontrib>Lang, Sue</creatorcontrib><creatorcontrib>van Steensel, Maurice A. M.</creatorcontrib><creatorcontrib>Martin, Patricia E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Experimental dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Donnelly, Steven</au><au>English, Grant</au><au>de Zwart-Storm, Eugene A.</au><au>Lang, Sue</au><au>van Steensel, Maurice A. M.</au><au>Martin, Patricia E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis</atitle><jtitle>Experimental dermatology</jtitle><addtitle>Exp Dermatol</addtitle><date>2012-08</date><risdate>2012</risdate><volume>21</volume><issue>8</issue><spage>592</spage><epage>598</epage><pages>592-598</pages><issn>0906-6705</issn><eissn>1600-0625</eissn><abstract>Mutations in Connexin26 (Cx26) give rise to a spectrum of dominantly inherited hyperproliferating skin disorders, the severest being keratitis–ichthyosis–deafness (KID) syndrome, an inflammatory skin disorder, with patients prone to opportunistic infections. We compared the effects of peptidoglycan (PGN) extracted from the skin commensal Staphylococcus epidermidis and the opportunistic pathogen Staphylococcus aureus on interleukin‐6 and connexin expression in HaCaT cells (a keratinocyte cell line) and connexin channel activity in HaCaT and HeLa (connexin deficient) cells transfected to express KID and non‐KID Cx26 mutations. In both cell types, PGN from S. aureus induced hemichannel activity in cells expressing KID mutants as monitored by ATP release assays following 15‐min challenge, while that from S. epidermidis evoked a response in HeLa cells. In KID mutant expressing cells, ATP release was significantly higher than in cells transfected with wild‐type Cx26. No ATP release was observed in non‐KID mutant transfected cells or in the presence of carbenoxolone, a connexin channel blocker. PGN isolated from S. aureus but not S. epidermidis induced interleukin‐6 and Cx26 expression in HaCaT cells following 6‐h challenge. Challenge by PGN from S. aureus evoked a greater interleukin‐6 response in cells expressing KID mutants than in cells expressing wtCx26 or non‐KID mutants. This response returned to basal levels if acute KID hemichannel signalling was blocked prior to PGN challenge. Thus, KID mutants form channels that can be triggered by the pro‐inflammatory mediator PGN from opportunistic pathogens but not skin commensals, providing further insight into the genotype–phenotype relationship of Cx26 disorders.</abstract><cop>Oxford</cop><pub>Blackwell Publishing Ltd</pub><pmid>22643125</pmid><doi>10.1111/j.1600-0625.2012.01521.x</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0906-6705 |
ispartof | Experimental dermatology, 2012-08, Vol.21 (8), p.592-598 |
issn | 0906-6705 1600-0625 |
language | eng |
recordid | cdi_proquest_miscellaneous_1038601362 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Adenosine Triphosphate - metabolism ATP Bacterial diseases Biological and medical sciences Carbenoxolone - pharmacology Cell Line Channel gating Commensals Complex syndromes Connexin 26 connexin26 Connexins Connexins - genetics Connexins - metabolism Deafness - genetics Dermatology disorder Dyskeratosis Dysplasia Epidermis - abnormalities Genotype HeLa Cells hemichannel activity Human bacterial diseases Humans Ichthyosis - genetics Infectious diseases Inflammation Inflammatory diseases innate immunity Interleukin 6 Interleukin-6 - metabolism Keratinocytes Keratinocytes - drug effects Keratinocytes - metabolism Keratinocytes - pathology Keratitis - genetics KID syndrome Medical genetics Medical sciences Mutation Mutation - genetics Opportunist infection Pathogens Peptidoglycan - metabolism Peptidoglycan - pharmacology peptidoglycans Phenotype Skin Skin Diseases, Genetic - genetics Staphylococcal infections, streptococcal infections, pneumococcal infections Staphylococcus aureus Staphylococcus aureus - metabolism Staphylococcus epidermidis Staphylococcus epidermidis - metabolism Transfection |
title | Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T23%3A37%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20susceptibility%20of%20Cx26%20mutations%20associated%20with%20epidermal%20dysplasias%20to%20peptidoglycan%20derived%20from%20Staphylococcus%20aureus%20and%20Staphylococcus%20epidermidis&rft.jtitle=Experimental%20dermatology&rft.au=Donnelly,%20Steven&rft.date=2012-08&rft.volume=21&rft.issue=8&rft.spage=592&rft.epage=598&rft.pages=592-598&rft.issn=0906-6705&rft.eissn=1600-0625&rft_id=info:doi/10.1111/j.1600-0625.2012.01521.x&rft_dat=%3Cproquest_pubme%3E1038601362%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1024477736&rft_id=info:pmid/22643125&rfr_iscdi=true |